Agenus reported $-34337000 in EBITDA for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Agenus AGEN:US $ -34.34M 20.08M
Amgen AMGN:US $ 3004M 337M
AstraZeneca AZN:LN 3562M 625M
Bristol Myers Squibb BMY:US $ 5780M 8M
Chemocentryx CCXI:US $ -37.22M 1.82M
CSL CSL:AU $ 2.66B 1.45B
Dynavax Technologies DVAX:US $ 128.77M 96.32M
Eli Lilly And LLY:US $ 1999.4M 1006.2M
Genocea Biosciences GNCA:US $ -15.37M 2.37M
Gilead Sciences GILD:US $ 2585M 837M
GlaxoSmithKline GSK:LN 2447M 673M
Glaxosmithkline GSK:US $ 2447M 673M
Johnson & Johnson JNJ:US $ 8036M 1273M
Karyopharm Therapeutics KPTI:US $ -42759000 8.35M
Macrogenics MGNX:US $ -38931000 24.79M
Merck MRK:GR € 1791M 161M
Northwest Biotherapeutics NWBO:US -12186000 1.59M
Novartis NOVN:VX SF 4660M 108M
Pfizer PFE:US $ 12921M 1739M
Regeneron Pharmaceuticals REGN:US $ 1381.3M 20.4M
Sangamo Biosciences SGMO:US $ -42.85M 0.42M
Veracyte VCYT:US $ -0.94M 7.75M
YTE INCY:US $ 276.8M 132.69M